Price
No data yet.
Social Signal Score
Analyst Ratings
2 analystsRevenue
$16.36B+10.20%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Markus Kamieth
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 108,251
- Beta
- 0.80
- Country
- DE
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 2.35
Financials
Revenue
$16.36B+10.2%Net Income
$155.00M-77.5%EBITDA
$826.00M-67.7%Free Cash Flow
$524.00M-19.0%EPS (diluted)
$0.04-76.3%Shares Outstanding (diluted)
3.44B-6.1%Operating Expenses
$2.60BCash & Debt
$4.12BReturn of Capital
$337.00MDividend per Share
$0.66Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $57.30B | $1.56B | $0.44 |
| 2024 | $65.26B | $1.30B | $0.36 |
| 2023 | $68.90B | $225.00M | $0.06 |
| 2022 | $87.33B | $-391.00M | $-0.11 |
| 2021 | $78.60B | $5.52B | $1.50 |
| 2020 | $59.15B | $-1.47B | $-0.40 |
| 2019 | $59.32B | $2.55B | $0.69 |
| 2018 | $62.67B | $4.71B | $1.28 |
| 2017 | $64.47B | $6.08B | $1.66 |
| 2016 | $57.55B | $4.06B | $1.11 |
| 2015 | $70.45B | $3.99B | $1.09 |
| 2014 | $74.33B | $5.16B | $1.40 |
| 2013 | $73.97B | $4.84B | $1.31 |
| 2012 | $78.73B | $4.88B | $1.31 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from BASFY's reported EPS growth of -8.0% a year over 13 years.
- EPS in 5 years
- $0.29
- Implied price
- $7.18
- Return from $13.53
- -11.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $3.57 — -73.6% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 17 | 21 | 25 | 29 | 33 |
|---|---|---|---|---|---|
| -18.0% | -27.3% | -24.2% | -21.5% | -19.1% | -17.0% |
| -13.0% | -22.9% | -19.5% | -16.7% | -14.2% | -11.9% |
| -8.0% | -18.4% | -14.9% | -11.9% | -9.2% | -6.9% |
| -3.0% | -14.0% | -10.3% | -7.1% | -4.3% | -1.8% |
| 2.0% | -9.6% | -5.7% | -2.3% | 0.6% | 3.3% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
75+50.00%Social Signal Score
Mentions (28)
- Newswsj.com·3d ago·Neutral
Evonik Shares Tumble After BASF Ends Takeover Efforts German chemicals company BASF said it dropped its efforts to acquire Evonik, following the company's rejection of two offers.
View source ↗ - Newsreuters.com·3d ago·Neutral
BASF says it ends pursuit of Evonik after bids were rejected BASF says it ends pursuit of Evonik after bids were rejected
View source ↗ - Newszacks.com·5d ago·Positive
BASF's Nemasphere Technology Boosts Seed Solutions Growth Prospects BASFY's Nemasphere technology boosts Seed Solutions growth prospects with strong nematode control and over 300 million euros in peak sales potential.
View source ↗ - Newszacks.com·10d ago·Neutral
BASF Expands MDI Production Capacity With $1B Geismar Investment BASFY completes its $1 billion Geismar expansion, nearly doubling MDI capacity to 600,000 metric tons annually to meet growing polyurethane demand across industries.
View source ↗ - Newsreuters.com·13d ago·Neutral
BASF, Evonik management held talks over weekend, sources say BASF, Evonik management held talks over weekend, sources say
View source ↗ - Newswsj.com·23d ago·Neutral
BASF's $12.5 Billion Takeover Bid for Evonik Rebuffed The news is a blow to the German chemical company's attempts to challenge rivals from Asia and the Middle East.
View source ↗ - Newsreuters.com·23d ago·Neutral
Evonik likely to reject BASF's sweetened $12.5 billion bid, FT reports Evonik likely to reject BASF's sweetened $12.5 billion bid, FT reports
View source ↗ - Newszacks.com·24d ago·Neutral
BASFY Launches Lincare to Improve Post-Laser Skincare BASF launches Lincare for post-laser skincare, delivering faster skin barrier recovery, improved rejuvenation and enhanced skin density in clinical tests.
View source ↗ - Newsseekingalpha.com·24d ago·Positive
BASF SE (BASFY) Q3 2026 Press Conference Call Transcript BASF SE (BASFY) Q3 2026 Press Conference Call Transcript
View source ↗ - Newszacks.com·25d ago·Neutral
BASFY Expands APG Manufacturing Facility in Cincinnati BASF expands APG production capacity in Cincinnati to meet growing North American demand for biodegradable surfactants and strengthen regional supply reliability.
View source ↗ - Newsmarketbeat.com·25d ago·Neutral
What Basf (BAS) Said on Its Q3 Earnings Call Basf ETR: BAS reported higher third-quarter earnings and raised the lower end of its 2026 EBITDA before special items outlook, citing improved pricing, volume growth across its core businesses and lower fixed costs. The company also said it is continuing to reduce debt, execute share buybacks and evaluate a potential combination with Evonik, while emphasizing that any transaction would need to be value-accretive.
View source ↗ - Newsseekingalpha.com·25d ago·Positive
BASF SE (BASFY) Q3 2026 Earnings Call Transcript BASF SE (BASFY) Q3 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·25d ago·Neutral
Basf Q3 Earnings Call Highlights Basf ETR: BAS reported higher third-quarter earnings before special items, supported by price increases, volume growth and lower fixed costs across its core businesses, while narrowing its full-year earnings outlook upward.
View source ↗ - Newswsj.com·25d ago·Neutral
BASF Lifts Full-Year Earnings Outlook After Strong Third Quarter The chemicals giant booked sales that beat analysts' projections and came in 14% higher compared with the prior-year period.
View source ↗ - Newszacks.com·27d ago·Neutral
BASFY Expands Taiwan Operations to Support Next-Gen Manufacturing BASF is expanding its Taiwan semiconductor operations to meet rising AI-driven demand for advanced materials, boost supply reliability and strengthen innovation.
View source ↗ - Newszacks.com·39d ago·Neutral
BASFY Launches GLYTHERMIN to Meet Cooling Needs of Data Centers BASF launches GLYTHERMIN coolants to meet rising AI data center cooling needs, combining advanced corrosion protection with thermal management solutions.
View source ↗ - Newsreuters.com·44d ago·Neutral
BASF could make higher offer for Evonik, sources say BASF could make a higher offer for Evonik if there are talks with the specialty chemicals maker, sources close to BASF told Reuters on Friday.
View source ↗ - Newszacks.com·58d ago·Negative
BASFY Launches Lower-Carbon Paper Coating Dispersions BASF launches paper coating dispersions with 20-45% lower carbon footprints, helping customers cut Scope 3.1 emissions without requalification.
View source ↗ - Newswsj.com·58d ago·Negative
Chemicals Giant BASF Moves for Rival Evonik The German company said it entered initial talks over a takeover of smaller peer Evonik, a tie-up that would bolster BASF's dominant position in Europe's chemicals industry.
View source ↗ - Newsreuters.com·58d ago·Neutral
BASF approaches rival Evonik with merger proposal, FT reports Germany's BASF has approached rival Evonik and its largest shareholder, the RAG Foundation, with a proposal for a merger, the Financial Times reported on Friday, sending Evonik shares to a three-month high.
View source ↗ - Newszacks.com·61d ago·Neutral
BASF Conducts Feasibility Study for MDI Production Investment in India BASFY is evaluating an MDI production complex in Dahej, India, to meet rising regional demand and strengthen its local manufacturing footprint.
View source ↗ - Newsseekingalpha.com·67d ago·Positive
BASF: Announced IPO Masks Challenges BASF is executing its 'Winning Ways' strategy, focusing on cost savings, capex reduction, and divestments to improve financial flexibility. Divestments, including the Coatings and planned Agricultural IPO, will shrink EBITDA, making ambitious €7-9 billion post-IPO targets challenging for the core business. Shareholder returns are prioritized with €8 billion in dividends and €4 billion in buybacks through 2028, largely funded by divestment proceeds rather than
View source ↗ - Newszacks.com·68d ago·Positive
BASFY's Durasorb Technology Gains Traction in Cheniere LNG Operations BASF's Durasorb LNG MAX gains traction at Cheniere's Corpus Christi LNG facility, with rollout across all trains targeted by end-2027.
View source ↗ - Newsreuters.com·69d ago·Neutral
BASF mandates banks for planned agricultural business listing BASF said on Monday it had mandated Citi, Deutsche Bank, Goldman Sachs and J.P. Morgan as global coordinators for the planned listing of its Agricultural Solutions business.
View source ↗ - Newszacks.com·72d ago·Negative
BASFY Adds Low-Emission PU Catalyst to Its Amine Catalyst Portfolio BASF expands its amine catalyst portfolio with Lupragen BisDMAPU, a low-emission solution for flexible PU foams and other applications.
View source ↗ - Newsseekingalpha.com·74d ago·Positive
BASF: Spotlight On Ongoing Buybacks And Planned Spin-Off I initiate BASF SE (BASFY) with a Buy rating, citing strong capital returns and an active €1B buyback program. The planned 2027 spin-off of Agricultural Solutions is a key catalyst, likely narrowing the conglomerate discount and supporting a higher EV/EBITDA multiple. BASFY's forward shareholder yield exceeds 6%, supported by disciplined capital allocation, robust cash flows, and a minimum €2.25 annual dividend.
View source ↗ - Newszacks.com·80d ago·Neutral
BASFY Strengthens Acid Chlorides and Chloroformates Production BASF modernizes its Ludwigshafen ACCF plant, lifting capacity by about 30% and cutting the portfolio's carbon footprint by an average of 19%.
View source ↗ - Newszacks.com·94d ago·Neutral
BASFY Opens Global SAP and Diaper Performance Lab in Mumbai BASFY has opened a Mumbai performance lab to provide global technical support and accelerate innovation in superabsorbents and hygiene solutions.
View source ↗
Earnings
Fri, Feb 26(in 3 months)
Consensus estimate $0.04 per share
Typical surprise +7.9% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Oct 28$0.21 vs $0.12beat
- Wed, Jul 29$0.37 vs $0.24beat
- Thu, Apr 30$0.39 vs $0.31beat
- Fri, Feb 27$-0.12 vs $0.05miss
- Wed, Oct 29$0.05 vs $0.11miss
- Wed, Jul 30$0.14 vs $0.20miss
Estimates and results for BASFY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
- Greg Gianfortehouse · MT00 · disclosed Dec 2, 2020 (19d later)Buy$15,001 - $50,000
- Greg Gianfortehouse · MT00 · disclosed Jan 23, 2019 (33d later)Sell$15,001 - $50,000
- Thomas Charles MacArthurhouse · NJ03 · disclosed Jan 11, 2019 (32d later)Sell$15,001 - $50,000
- Greg Gianfortehouse · MT00 · disclosed Dec 11, 2018 (22d later)Sell$1,001 - $15,000
- Thomas Charles MacArthurhouse · NJ03 · disclosed Oct 6, 2018 (23d later)Buy$15,001 - $50,000
- Shelley Moore Capitosenate · WV · disclosed Oct 16, 2017 (41d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
